x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Breast Cancer Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

science medicine

All Episodes

58:40

Antibody-Drug Conjugates for Breast Cancer — Year in...

Breast Cancer Update ·

2026/03/02

Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Sara M Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data with antibody-drug conjugates in the management of breast cancer.CME information and select publications here.

en

02:01:07

Endocrine-Based Therapy for HR-Positive Breast Cancer...

Breast Cancer Update ·

2026/01/27

Dr Angela DeMichele from the Abramson Cancer Center in Philadelphia, Pennsylvania, Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Seth Wander from Massachusetts General Hospital in Boston discuss real-world cases and recent clinical data surrounding the management of HR-positive breast cancer.CME

en

01:58:18

HER2-Positive Breast Cancer — Proceedings from a San...

Breast Cancer Update ·

2026/01/14

Prof Giuseppe Curigliano from the University of Milan in Italy, Prof Nadia Harbeck from LMU University Hospital in Munich, Germany, Dr Ian E Krop from Yale Cancer Center, Dr Nancy U Lin from Dana-Farber Cancer Institute and Dr Joyce O’Shaughnessy from Baylor University Medical Center discuss real-world cases and recent clinical data pertinent to the management of HER2-positive breast cancer. CME information and select publications here.

en

01:30:21

Antibody-Drug Conjugates for Breast Cancer —...

Breast Cancer Update ·

2026/01/08

Dr Javier Cortés from the International Breast Cancer Center in Barcelona, Spain, Dr Rita Nanda from the University of Chicago, Prof Peter Schmid from Barts Cancer Institute in London, United Kingdom, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood discuss key clinical data with antibody-drug conjugates for metastatic breast cancer and their expert perspectives surrounding its clinical applications.CME information and select publications here.

en

01:00:14

Toxicities Associated with Antibody-Drug Conjugates...

Breast Cancer Update ·

2025/12/23

Dr Lisa A Carey from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and Dr Rita Nanda from The University of Chicago in Illinois engage in an evidence-based discussion around real-world cases involving common toxicities associated with antibody-drug conjugates in the management of breast cancer.CME information and select publications here.

en

01:27:39

Breast Cancer — Highlights from the 2025 ESMO Annual...

Breast Cancer Update ·

2025/12/08

Prof Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss the implications of clinical findings in breast cancer recently presented at the 2025 ESMO Annual Meeting.CME information and select publications here.

en

15:27

Breast Cancer — Microlearning Activity Issue 3 with...

Breast Cancer Update ·

2025/12/05

Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.CME information and select publications here.

en

16:55

Breast Cancer — Microlearning Activity 2 with Dr...

Breast Cancer Update ·

2025/12/02

Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.CME information and select publications here.

en

58:54

Metastatic Breast Cancer — Optimizing the Use of Oral...

Breast Cancer Update ·

2025/11/29

Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer.CME information and select publications here.

en

12:49

Breast Cancer — Microlearning Activity 1 with Dr...

Breast Cancer Update ·

2025/11/26

Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.CME information and select publications here.

en

58:36

HR-Positive Metastatic Breast Cancer — An Interview...

Breast Cancer Update ·

2025/11/20

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, reviews available clinical data with PROTAC estrogen receptor degraders and their potential role in the management of HR-positive metastatic breast cancer. CME information and select publications here.

en

02:30:36

ER-Positive Metastatic Breast Cancer — A Roundtable...

Breast Cancer Update ·

2025/11/14

Prof Francois-Clement Bidard from the Institut Curie in Paris, France, Dr Hope S Rugo from the City of Hope Comprehensive Cancer Center in Duarte, California, Dr Rebecca Shatsky from the University of California San Diego Moores Cancer Center and Dr Seth Wander from Massachusetts General Hospital in Boston discuss recent updates on available and emerging treatment strategies involving oral SERDs for ER-positive metastatic breast cancer.CME information and select publications here.

en

01:57:51

Breast Cancer — Proceedings from a Multitumor...

Breast Cancer Update ·

2025/11/10

DrHaroldJ Burstein, DrMatthewPGoetz, DrHeatherMcArthurand DrRitaNandashare their perspectives on the evolving therapeutic landscape for patients with breast cancer.CME information and select publications here.

en

41:17

ER-Positive Metastatic Breast Cancer — An Interview...

Breast Cancer Update ·

2025/11/05

ProfPatrick Neven from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies with oral SERDs for ER-positive metastatic breast cancer.CME information and select publications here.

en

15:40

Breast Cancer — 5-Minute Journal Club Issue 4 with Dr...

Breast Cancer Update ·

2025/10/27

Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer.CME information and select publications here.

en

56:46

Metastatic Breast Cancer — Current and Future...

Breast Cancer Update ·

2025/10/21

Dr Aditya Bardia and Dr Adam M Brufsky discuss published and emerging datasets investigating the incorporation of antibody-drug conjugates into the treatment of metastatic breast cancer.CME information and select publications here.

en

43:40

HR-Positive and Triple-Negative Metastatic Breast...

Breast Cancer Update ·

2025/10/14

Dr Laura Huppert from the University of California, San Francisco, discusses approved and investigational antibody-drug conjugates in the current and future management of HR-positive and triple-negative metastatic breast cancer.CME information and select publications here.

en

01:02:01

Breast Cancer — An ASCO 2025 Review

Breast Cancer Update ·

2025/10/07

Dr Sara A Hurvitz and Dr Sara M Tolaney summarize the treatment landscape for breast cancer and discuss the implications of clinical findings recently presented at the 2025 ASCO Annual Meeting.CME information and select publications here.

en

21:51

Breast Cancer — 5-Minute Journal Club Issue 3 with Dr...

Breast Cancer Update ·

2025/09/29

Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer.CME information and select publications here.

en

40:53

Metastatic BRCA-Negative, Triple-Negative Breast...

Breast Cancer Update ·

2025/09/23

Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.CME information and select publications here.

en

542 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter